These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 35662813)
1. Lentiviral gene therapy prevents anti-human acid α-glucosidase antibody formation in murine Pompe disease. Liang Q; Vlaar EC; Catalano F; Pijnenburg JM; Stok M; van Helsdingen Y; Vulto AG; Unger WWJ; van der Ploeg AT; Pijnappel WWMP; van Til NP Mol Ther Methods Clin Dev; 2022 Jun; 25():520-532. PubMed ID: 35662813 [TBL] [Abstract][Full Text] [Related]
2. Partial phenotypic correction and immune tolerance induction to enzyme replacement therapy after hematopoietic stem cell gene transfer of alpha-glucosidase in Pompe disease. Douillard-Guilloux G; Richard E; Batista L; Caillaud C J Gene Med; 2009 Apr; 11(4):279-87. PubMed ID: 19263466 [TBL] [Abstract][Full Text] [Related]
3. Enhanced response to enzyme replacement therapy in Pompe disease after the induction of immune tolerance. Sun B; Bird A; Young SP; Kishnani PS; Chen YT; Koeberl DD Am J Hum Genet; 2007 Nov; 81(5):1042-9. PubMed ID: 17924344 [TBL] [Abstract][Full Text] [Related]
4. IGF2-tagging of GAA promotes full correction of murine Pompe disease at a clinically relevant dosage of lentiviral gene therapy. Liang Q; Catalano F; Vlaar EC; Pijnenburg JM; Stok M; van Helsdingen Y; Vulto AG; van der Ploeg AT; van Til NP; Pijnappel WWMP Mol Ther Methods Clin Dev; 2022 Dec; 27():109-130. PubMed ID: 36284764 [TBL] [Abstract][Full Text] [Related]
5. Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance Induction. Han SO; Ronzitti G; Arnson B; Leborgne C; Li S; Mingozzi F; Koeberl D Mol Ther Methods Clin Dev; 2017 Mar; 4():126-136. PubMed ID: 28344998 [TBL] [Abstract][Full Text] [Related]
6. Teaching tolerance: New approaches to enzyme replacement therapy for Pompe disease. Cousens LP; Mingozzi F; van der Marel S; Su Y; Garman R; Ferreira V; Martin W; Scott DW; De Groot AS Hum Vaccin Immunother; 2012 Oct; 8(10):1459-64. PubMed ID: 23095864 [TBL] [Abstract][Full Text] [Related]
8. Lentiviral Hematopoietic Stem Cell Gene Therapy Corrects Murine Pompe Disease. Stok M; de Boer H; Huston MW; Jacobs EH; Roovers O; Visser TP; Jahr H; Duncker DJ; van Deel ED; Reuser AJJ; van Til NP; Wagemaker G Mol Ther Methods Clin Dev; 2020 Jun; 17():1014-1025. PubMed ID: 32462050 [TBL] [Abstract][Full Text] [Related]
9. Non-depleting anti-CD4 monoclonal antibody induces immune tolerance to ERT in a murine model of Pompe disease. Sun B; Banugaria SG; Prater SN; Patel TT; Fredrickson K; Ringler DJ; de Fougerolles A; Rosenberg AS; Waldmann H; Kishnani PS Mol Genet Metab Rep; 2014; 1():446-450. PubMed ID: 27896120 [TBL] [Abstract][Full Text] [Related]
10. Antibody-mediated enzyme replacement therapy targeting both lysosomal and cytoplasmic glycogen in Pompe disease. Yi H; Sun T; Armstrong D; Borneman S; Yang C; Austin S; Kishnani PS; Sun B J Mol Med (Berl); 2017 May; 95(5):513-521. PubMed ID: 28154884 [TBL] [Abstract][Full Text] [Related]
11. Oral delivery of Acid Alpha Glucosidase epitopes expressed in plant chloroplasts suppresses antibody formation in treatment of Pompe mice. Su J; Sherman A; Doerfler PA; Byrne BJ; Herzog RW; Daniell H Plant Biotechnol J; 2015 Oct; 13(8):1023-32. PubMed ID: 26053072 [TBL] [Abstract][Full Text] [Related]
12. Synergistic Efficacy from Gene Therapy with Coreceptor Blockade and a β2-Agonist in Murine Pompe Disease. Han SO; Li S; Bird A; Koeberl D Hum Gene Ther; 2015 Nov; 26(11):743-50. PubMed ID: 26417913 [TBL] [Abstract][Full Text] [Related]
13. Immunological challenges and approaches to immunomodulation in Pompe disease: a literature review. Desai AK; Li C; Rosenberg AS; Kishnani PS Ann Transl Med; 2019 Jul; 7(13):285. PubMed ID: 31392197 [TBL] [Abstract][Full Text] [Related]
14. Enhanced efficacy from gene therapy in Pompe disease using coreceptor blockade. Han SO; Li S; Brooks ED; Masat E; Leborgne C; Banugaria S; Bird A; Mingozzi F; Waldmann H; Koeberl D Hum Gene Ther; 2015 Jan; 26(1):26-35. PubMed ID: 25382056 [TBL] [Abstract][Full Text] [Related]